ArticleEuropean journal of medical research2025
Anatomic-size determinants drive therapeutic decisions in inflammatory fibroid polyps: a retrospective study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveInflammatory fibroid polyps (IFPs), uncommon benign growths in the gastrointestinal tract, currently lack standardized treatment protocols. Our investigation sought to determine crucial clinical indicators for therapeutic decision-making in IFP management.
methodsWe conducted a retrospective analysis of 114 hospitalized patients from The First Affiliated Hospital of Fujian Medical University and Fuzhou University Affiliated Provincial Hospital between January 2015 and April 2025. Comprehensive evaluation included patient demographics, lesion features (anatomical distribution, dimensions, pathological characteristics), and therapeutic outcomes. Statistical approaches incorporated independent sample t-tests, χ
resultsThe study cohort demonstrated a significant female predominance (male-to-female ratio 1:2.2), with gender showing a significant association with IFP surface morphology (p = 0.023), median patient age of 57.92 years with the majority asymptomatic (69.3%), anatomical distribution: gastric (73.8%), colorectal (15.6%), and small intestinal (10.7%). Absolute surgical indication for small intestinal IFPs (vs stomach, OR = 20.624, p < 0.001). Markedly increased surgical likelihood for lesions exceeding 1.65 cm (area under curve 0.859; 82.6% sensitivity, 74.7% specificity). Differential complication rates: surgery cohort 30.4% vs endoscopy 7.7% (p = 0.008).
conclusionsOur research establishes a novel dual-parameter decision framework for IFP treatment: anatomic-driven, lesions in the jejunum and ileum warrant primary surgical resection; size-dependent, 1.65 cm cutoff optimizes endoscopic safety for gastric/colorectal lesions. This discovery provides an evidence-based basis for individualized diagnosis and treatment of IFP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.